EP3133070

ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    24.11.2010
  • EP published:
    14.8.2019
  • EP application number:
    16175117.7
  • Max expiry date:
    23.11.2030
  • Title:
    ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT

Timeline

Today
24.11.2010EP application
14.8.2019EP Publication

Owner

  • Name:
    Genzyme Corporation
  • Address:
    50 Binney Street, 02142, Cambridge, MA, US

Inventor

  • Name:
    LIU, Hanlan
  • Address:
    Lexington, MA, US
  • Name:
    WILLIS, Chris
  • Address:
    Southborough, MA, US
  • Name:
    BHARDWAJ, Renu
  • Address:
    Ashland, MA, US
  • Name:
    COPELAND, Diane P.
  • Address:
    Billerica, MA, US
  • Name:
    HARIANAWALA, Abizer
  • Address:
    Acton, MA, US
  • Name:
    SKELL, Jeffrey
  • Address:
    Westborough, MA, US
  • Name:
    MARSHALL, John
  • Address:
    Bridgewater, NJ, US
  • Name:
    KOCHLING, Jianmei
  • Address:
    Wellesley, MA, US
  • Name:
    PALACE, Gerard
  • Address:
    Framingham, MA, US
  • Name:
    PETERSCHMITT, Judith
  • Address:
    Watertown, MA, US
  • Name:
    SIEGEL, Craig
  • Address:
    Woburn, MA, US
  • Name:
    CHENG, Seng
  • Address:
    Natick, MA, US

Priority

  • Number:
    264748 P
  • Date:
    27.11.2009
  • Country:
    US

Classification

  • Categories:
    C07D 405/06, A61K 45/06, A61K 31/4025, A61P 35/00

Upload documents